SPOCK: Master regulator of malignant tumors (Review)

Mingyuan Xiao1, Jiancheng Xue2, Enli Jin1

  • 1Department of Rehabilitation, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110134, P.R. China.

PubMed

Insights

The SPOCK gene family, including SPOCK1, SPOCK2, and SPOCK3, plays a crucial role in regulating cancer progression and cell proliferation. This review explores their function and potential for targeted cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • The SPOCK (SPARC/osteonectin, CWCV and Kazal-like domain proteoglycan) gene family comprises highly conserved multidomain proteins.
  • SPOCK1, SPOCK2, and SPOCK3 are major extracellular matrix glycoproteins with significant roles in biological processes.

Purpose of the Study:

  • To review the molecular structure, tissue distribution, and biological functions of the SPOCK protein family.
  • To summarize the association of the SPOCK gene family with various types of cancer.
  • To discuss the potential of SPOCK-targeted therapies for clinical applications.

Main Methods:

  • Literature review of existing studies on the SPOCK gene family.
  • Analysis of molecular structure and protein interactions.
  • Investigation of SPOCK gene expression and function in cancer models.

Main Results:

  • SPOCK proteins are implicated in regulating matrix metalloproteinases (MMPs), impacting epithelial-mesenchymal transition.
  • They influence cell cycle regulation and inhibit tumor cell proliferation by affecting PI3K/AKT signaling.
  • SPOCK family members are associated with microRNAs, modulating downstream gene expression.

Conclusions:

  • The SPOCK gene family exhibits significant potential as cancer-regulating genes.
  • Understanding SPOCK's role is crucial for developing novel therapeutic strategies.
  • Further research into SPOCK-targeted therapy may offer new clinical treatment options.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K